UBS AM’s Coherus Oncology CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $452K | Hold |
|
|||||
|
2023
Q3 | $508K | Buy |
|
|||||
|
2023
Q2 | $779K | Hold |
|
|||||
|
2023
Q1 | $779K | Buy |
|
|||||
|
2022
Q4 | $831K | Buy |
|
|||||
|
2022
Q3 | $543K | Sell |
|
|||||
|
2022
Q2 | $455K | Sell |
|
|||||
|
2022
Q1 | $1.02M | Hold |
|
|||||
|
2021
Q4 | $1.26M | Hold |
|
|||||
|
2021
Q3 | $1.27M | Hold |
|
|||||
|
2021
Q2 | $1.09M | Sell |
|
|||||
|
2021
Q1 | $3.09M | Sell |
|
|||||
|
2020
Q4 | $39.2M | Buy |
|
|||||
|
2020
Q3 | $31.1M | Sell |
|
|||||
|
2020
Q2 | $32.8M | Sell |
|
|||||
|
2020
Q1 | $30.2M | Sell |
|
|||||
|
2019
Q4 | $34.5M | Buy |
|
|||||
|
2019
Q3 | $31.8M | Buy |
|
|||||
|
2019
Q2 | $33.6M | Sell |
|
|||||
|
2019
Q1 | $21.4M | Buy |
|
|||||
|
2018
Q4 | $11.9M | Buy |
|
|||||
|
2018
Q3 | $20.8M | Sell |
|
|||||
|
2018
Q2 | $18.4M | Sell |
|
|||||
|
2018
Q1 | $14.6M | Sell |
|
|||||
|
2017
Q4 | $12.3M | Buy |
|
|||||
|
2017
Q3 | $17.6M | Sell |
|
|||||
|
2017
Q2 | $20M | Buy |
|
|||||
|
2017
Q1 | $19M | Buy |
|
|||||
|
2016
Q4 | $14.1M | Buy |
|
|||||
|
2016
Q3 | $504K | Buy |
|
|||||
|
2016
Q2 | – | Sell |
|
|||||
|
2016
Q1 | $203K | Sell |
|
|||||
|
2015
Q4 | $264K | Buy |
|